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Supplementary Figures 
 
Supplementary Figure 1: a. ​Percentage of trimmed reads mapping to abundant sequences (ribosomal RNA,              
transfer RNA, mitochondrial RNA). ​b​. Length distribution of reads after removal of abundant sequences showing 28,                
29, 30 as the predominant lengths of ribosome protected fragments (RPFs). ​c​. Average expression (Transcripts per                
million mapped reads) in each region of protein coding genes showing higher coverage on coding sequence (CDS)                 
compared to the untranslated regions as expected for RPFs. ​d​. Number of reads mapping to the human genome                  
(hg38) per sample using STAR aligner. Quality statistics calculated and visualized using MultiQC​1​. 
 
 
Supplementary Figure 2: a-b. ​Principal component analysis (top 500 genes, ranked by variance across samples) of                
the RNA-seq ​(a) and Ribo-seq data ​(b) across the fibrotic response. PC1 accounts for 45-46% of the variance in the                    
gene expression and samples are grouped by patient indicating a patient batch effect (​a: i b: i​). After batch                   
correction, PC1 accounts for 59%-62% of the variance and now separates the time-points (​a: ii, b: ii)​. ​c. ​Ribo-seq                   
and RNA-seq counts for Integrin 7A exhibit a strong patient effect, not allowing detection as a DTEG ​(c: i)​, which is                     
ameliorated after batch correction on normalized VST counts ​(c: ii)​. Batch effect removal was carried out using limma                  
package​2​ in R​. 
 
Supplementary Figure 3: a-f: ​Western blotting of exclusive (FTL (​a​), FTH1 (​c​), ITGA3 (​d​)), intensified (HES1 (​e​))                 
and buffered (PRKG1 (​f​)) genes with control (GAPDH (​b​)) in two patients at baseline and 4 time points after TGFβ1                    
stimulation in primary human cardiac fibroblasts. ​g-i: ​Log-fold changes in the mRNA and ribosome occupancy at 2                 
hours (​g​), 6 hours (​h​) and 24 hours (​i​) after TGFβ1 stimulation. DTG: Differentially transcribed genes, DTEG:                 
Differential translational-efficiency genes. ​j:​ DTGs and DTEGs detected at each time point after TGFβ1 stimulation. 
 
 
Supplementary Figure 4: ​Hierarchical clustering of different regulatory groups including ​a. ​F: ​forwarded ​b. E:               
exclusive ​c. B: buffered, B’: completely buffered (special case) and ​d. I: intensified at the translational level. Refer                  
Supplementary table 4 for gene regulatory groups. The cluster IDs are represented as (gene regulatory               
group)(#):(Number of genes in that cluster). For instance, F1:359 is the first forwarded cluster with 359 genes. The                  
clusters are ordered based on cluster size in each regulatory class. 
 
 
 
 
Supplementary figure 5: Cardiac fibrosis markers in adult mouse heart tissue​3 ​and end-stage DCM patients​.               
a. t-SNE plot showing fibroblasts as one of the largest cell populations in adult mouse hearts. Expression of ​b.                   
Collagen I alpha 1, Col1a1, ​c. Collagen I alpha 2, Col1a2 and ​d. Collagen III alpha 1, Col3a1 is specific to                     
fibroblasts/myofibroblasts in adult mouse hearts and they are also ​e-g. upregulated in DCM patients (Fold change,                
FDR). ​h-i. ​Expression of Periostin, Postn (​h​) and Latent TGFβ binding protein 2, Ltbp2 (​i​) is also specific to                   
fibroblasts/myofibroblasts. 
 
 
 
 
Supplementary Figure 6: Genome-wide translational profiling of dilated cardiomyopathy patients. a. ​Control            
(n=108) and end-stage DCM patient (n=97) RNA-seq dataset was obtained from our previous study​4 for differential                
expression analysis. We generated Ribo-seq libraries (n=30, out of 97 DCM patients) to carry out translational                
efficiency analysis. ​b. ​Percentage of trimmed Ribo-seq reads mapping to abundant sequences (rRNA, tRNA,              
mitochondrial RNA). ​c​. Length distribution of reads after removal of abundant sequence mapped reads showing 28,                
29, 30 as the predominant lengths of ribosome protected fragments (RPFs). ​d​. Average expression (TPM) in each                 
region of protein coding genes showing higher coverage of coding sequence (CDS) as expected for RPFs. ​e​. Number                  
of reads mapping to the human genome (hg38) per sample. ​f.​ Average periodicity of 90% across all 30 samples. 
  
 
Supplementary Figure 7: ​a. Gene expression correlation (spearman ranked) of RNA-binding proteins with fibrosis              
markers. Only significant correlations based on p-value < 0.05 are shown. ​b. Hierarchical clustering to stratify patients                 
based on fibrosis marker gene expression. Tree was cut into four clusters, resulting in four groups of fibrogenic                  
marker expression severity.  
 
 
 
 
  
Supplementary figure 8: ​Knockdown of Quaking protein (QKI) and Pumilio RNA Binding Family Member 2 (PUM2)                
in baseline fibroblasts from three cardiac patients. NT: Non-targeting control siRNA. ​a. Western blot showing               
successful knockdown of QKI and PUM2 in all three patients. Full blots shown in ​b-d. for PUM2 (b), QKI (c) and                     
loading control (d). ​e. Microscopic images show fibroblasts with immunostaining for ɑ-smooth muscle actin (ACTA2).               
Scale bar equals 50µm. ​f. Fluorescence quantified on the Operetta high-content imaging platform after              
immunostaining for ACTA2 (28 measurements across four wells) and normalized for cell count. g. Total concentration                
of MMP2 in the supernatant (n=3, biologically independent samples) was quantified by ELISA. P-values were               
determined by one-way ANOVA and corrected for comparisons to the same sample (NT) using Dunnett’s test. n.s.                 
not significant.  
 
 
 
 
Supplementary figure 9: ​Common pro-fibrotic response in different datasets of fibrotic disease. a. Correlation              
of fold changes after TGFβ1 stimulation in atrial and ventricular fibroblasts. ​b. Correlation of expression (logTPM) in                 
TGFβ1 stimulated atrial fibroblasts and end-stage DCM patients. Genes in GO terms like actin binding, ECM                
structural constituent and cytoskeletal protein binding highlighted. ​c. Significant overlap of genes dysregulated in              
TGFβ1 stimulated atrial fibroblasts and DCM patients. Blue: Background distribution of random overlap. Red: True               
overlap.  
 
  
Supplementary Tables 
 
Supplementary table 1: ​Patient information  
for four male chinese individuals undergoing coronary  
artery bypass grafting 
Patient Age 
P1 59 
P2 52 
P3 57 
P4 51 
  
Supplementary table 2: ​Antibody ​information for Immunostaining, Operetta imaging, Confocal          
microscopy and Western Blotting 
Antibody Catalogue 
number 
Company Experiment 
ACTA2   ab7817 Abcam Operetta imaging and 
immunostaining confocal microscopy 
Collagen I ab34710 Abcam Operetta imaging 
POSTN  ab14041 Abcam Operetta imaging 
Goat anti-rabbit Alexa   
Flour-488 
150017 Abcam Operetta imaging 
Goat anti-mouse Alexa   
Flour-488  
150113 Abcam Operetta imaging 
Goat anti-mouse Alexa   
Fluor-555 
A-21424 Thermo Fisher Immunostaining confocal microscopy 
p-ERK1/2  4370 CST Western blotting 
ERK1/2 4695 CST Western blotting 
FTL ab109373 Abcam Western blotting 
FTH1 4393 CST Western blotting 
GAPDH 2118 CST Western blotting 
HES 11988 CST Western blotting 
ITGA3   sc-374242 SantaCruz Western blotting 
PKG-1 3248 CST Western blotting 
p-SMAD2 5339 CST Western blotting 
SMAD2 3108 CST Western blotting 
QKI  A300-183A Bethyl Labs Western blotting 
PUM2  A300-202A Bethyl Labs Western blotting 
 
  
Supplementary table 3: ​Software and tools used for data analysis  
Purpose Tool Version Command 
Demultiplexing bcl2fastq V2.19.0.3
16 
bcl2fastq --no-lane-splitting 
Adaptor 
trimming 
Trimmomatic V0.36 Ribo-seq​: java -jar trimmomatic-0.36.jar SE 
-phred33 infile outfile 
ILLUMINACLIP:All_TruSeqForTrimmomatic.fa:2:3
0:10 MAXINFO:20:0.5 MINLEN:20 
RNA-seq​: java -jar trimmomatic-0.36.jar PE 
-phred33 infiles outfiles 
ILLUMINACLIP:All_TruSeqForTrimmomatic.fa:2:3
0:10 MAXINFO:35:0.5 MINLEN:35 
Read clipping Fastx toolkit V0.0.14 fastx_trimmer -l 29 -Q33 -z 
Abundant 
sequence 
removal 
Bowtie2 V2.2.9 bowtie2 -L 20 -x human_abundant_combine  
Genome 
alignment 
STAR 020201 STAR --alignSJDBoverhangMin 1 
--alignSJoverhangMin 51 
--outFilterMismatchNmax 2 --alignEndsType 
EndToEnd 
Gene 
expression 
quantification 
Feature Counts 1.5.1 featureCounts -t CDS -g gene_id -O -s 1 -J -R -G 
Homo_sapiens.GRCh38.dna.primary_assembly.f
a -a GTF  
DTEG 
identification 
DESeq2 1.18.1 
 
Design =~ Patient + Time + Sequencing + 
Time:Sequencing 
 
https://github.com/SGDDNB/DTG-detection/blob/
master/getDTG.md 
Batch effect 
removal 
Limma​5 3.34.9 removeBatchEffect(counts, batch) 
Heatmap for 
periodicity 
pheatmap​6 1.0.8  pheatmap(data) 
Clustering Hclust ward.D​7 
cutreeDynamic​8 
 
1.63-1 
hclust(data, method=ward.D) 
 
 
 
 
Supplementary table 4: ​Classification of genes into regulation categories based on           
significance and fold change relationship. s: Significant changes calculated using DESeq2 with            
FDR<0.05; n.s: Not significant. FC: Fold change. Concordant: Significant fold changes are in the              
same direction. Counteracting: Significant fold changes are in the opposite direction. Schematic:            
ΔRPF: gray, ΔRNA: Blue, ΔTE: Red. 
Category RPF RNA ΔTE FC relationship DTG/DTEG Schematic 
Forwarded s s n.s. RPF concordant with RNA DTG 
 
Exclusive s n.s. s RPF changing 
independent of RNA 
DTEG 
 
Buffered 
(special 
case) 
n.s. s s ΔTE counteracting 
RNA; RPF FC = 0  
DTG & DTEG 
 
Buffered s s s ΔTE counteracting RNA  DTG & DTEG 
 
Intensified s s s ΔTE intensifying RNA DTG & DTEG 
 
 
Supplementary Files 
File 1: Log-fold changes and statistics for all protein-coding genes (Ensembl and Refseq) 
File 2: Genes in regulatory category: Buffered, Translation exclusive, Forwarded, Intensified 
File 3: Gene Ontology enrichment in gene regulatory groups 
File 4: Gene Ontology enrichment in transient gene clusters 
File 5: RNA-binding proteins and their target correlations in dilated cardiomyopathy patients 
File 6: KEGG pathway analysis of each RBPs target network 
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